118 related articles for article (PubMed ID: 7795182)
1. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
Severina IS
Biull Eksp Biol Med; 1995 Mar; 119(3):230-5. PubMed ID: 7795182
[No Abstract] [Full Text] [Related]
2. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
Severina IS
Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
[TBL] [Abstract][Full Text] [Related]
3. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
Severina IS
Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
5. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
Severina IS
Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
[TBL] [Abstract][Full Text] [Related]
6. [A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties].
Busygina OG; Belushkina NN; Grigor'ev NB; Severina IS
Biokhimiia; 1995 Sep; 60(9):1460-7. PubMed ID: 8562654
[TBL] [Abstract][Full Text] [Related]
7. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
Severina IS
Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of human platelet aggregation by a new class of soluble guanylate cyclase inhibitor, generating nitric oxide].
Belushkina NN; Grigor'ev NB; Severina IS
Biokhimiia; 1994 Nov; 59(11):1689-97. PubMed ID: 7873676
[TBL] [Abstract][Full Text] [Related]
10. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
Severina IS; Bussygina OG; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
[TBL] [Abstract][Full Text] [Related]
11. [The role of thiols in the stimulation of soluble guanylate cyclase by a new class of enzyme activators generating nitric oxide].
Belushkina NN; Riaposova IK; Severina IS
Biull Eksp Biol Med; 1997 Jan; 123(1):39-42. PubMed ID: 9213454
[No Abstract] [Full Text] [Related]
12. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
Karrenbrock B; Grewe R; Loeschke K; Gerzer R
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
[TBL] [Abstract][Full Text] [Related]
13. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
14. [A new class of soluble guanylate cyclase activators, generating nitric oxide].
Riaposova IK; Grigor'ev NV; Severina IS
Biokhimiia; 1994 Apr; 59(4):537-42. PubMed ID: 7912551
[TBL] [Abstract][Full Text] [Related]
15. Role of heme in the regulation of human and rat platelet soluble guanylate cyclases.
Severina IS; Busygina OG
Biochem Int; 1991 Apr; 23(6):1143-54. PubMed ID: 1683234
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of 1,2-diazetidine-1,2-di-N-oxides--a new class of soluble guanylate cyclase activators with vasodilatory properties.
Severina IS; Ryaposova IK; Volodarsky LB; Mozhuchin DC; Tichonov AYa ; Schwartz GYa ; Granik VG; Grigoryev DA; Grigoryev NB
Biochem Mol Biol Int; 1993 Jun; 30(2):357-66. PubMed ID: 8103389
[TBL] [Abstract][Full Text] [Related]
17. Soluble guanylate cyclase.
Poulos TL
Curr Opin Struct Biol; 2006 Dec; 16(6):736-43. PubMed ID: 17015012
[TBL] [Abstract][Full Text] [Related]
18. NO-independent regulatory site on soluble guanylate cyclase.
Stasch JP; Becker EM; Alonso-Alija C; Apeler H; Dembowsky K; Feurer A; Gerzer R; Minuth T; Perzborn E; Pleiss U; Schröder H; Schroeder W; Stahl E; Steinke W; Straub A; Schramm M
Nature; 2001 Mar; 410(6825):212-5. PubMed ID: 11242081
[TBL] [Abstract][Full Text] [Related]
19. [Heme deficiency of soluble guanylate cyclase in rat platelets].
Busygina OG; Severina IS
Biokhimiia; 1991 Mar; 56(3):487-93. PubMed ID: 1679351
[TBL] [Abstract][Full Text] [Related]
20. Contractility of late pregnant rat myometrium is refractory to activation of soluble but not particulate guanylate cyclase.
Fulep E; Vedernikov Y; Saade GR; Garfield RE
Am J Obstet Gynecol; 2001 Jul; 185(1):158-62. PubMed ID: 11483921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
